Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

In-Jin Jang

Showing results (201-210 of 292) with videos related to

Pageof 30
Sort By:
The Pharmacogenomics Journal|May 29, 2020
Oral absorption of voriconazole is affected by SLCO2B1 c.*396T>C genetic polymorphism in CYP2C19 poor metabolizersSang Won Lee, Jaeseong Oh, Andrew HyoungJin Kim, et al.
Drug Metabolism and Pharmacokinetics|December 21, 2020
The utility of CYP3A activity endogenous markers for evaluating drug-drug interaction between sildenafil and CYP3A inhibitors in healthy subjectsSoyoung Lee, Andrew HyoungJin Kim, Sumin Yoon, et al.
British Journal of Clinical Pharmacology|May 12, 2012
Apple juice greatly reduces systemic exposure to atenololHyewon Jeon, In-Jin Jang, SeungHwan Lee, et al.
Clinical Therapeutics|January 30, 2010
The effects of ketoconazole and rifampicin on the pharmacokinetics of mirodenafil in healthy Korean male volunteers: an open-label, one-sequence, three-period, three-treatment crossover studyKwang-Hee Shin, Bo-Hyung Kim, Tae-Eun Kim, et al.
Basic & Clinical Pharmacology & Toxicology|March 21, 2013
Pharmacokinetic-pharmacodynamic modelling of biomarker response to sitagliptin in healthy volunteersBo-Hyung Kim, Sung Eun Kim, Dongwoo Kang, et al.
Clinical Drug Investigation|October 1, 2013
Relationship between absolute neutrophil count profiles and pharmacokinetics of DA-3031, a pegylated granulocyte colony-stimulating factor (pegylated-G-CSF): a dose block-randomized, double-blind, dose-escalation study in healthy subjectsLi Young Ahn, Kwang-Hee Shin, Kyoung Soo Lim, et al.
Epilepsy Research|July 30, 2015
GWAS identifies two susceptibility loci for lamotrigine-induced skin rash in patients with epilepsyHui Won Jang, So Won Kim, Yang-Je Cho, et al.
Antimicrobial Agents and Chemotherapy|May 20, 2015
Pharmacokinetics of Second-Line Antituberculosis Drugs after Multiple Administrations in Healthy VolunteersSang-In Park, Jaeseong Oh, Kyungho Jang, et al.
Scientific Reports|May 12, 2017
Pharmacometabolomics for predicting variable busulfan exposure in paediatric haematopoietic stem cell transplantation patientsBora Kim, Ji Won Lee, Kyung Taek Hong, et al.
European Journal of Clinical Pharmacology|June 17, 2018
Effect of food on the pharmacokinetics of YH4808, a potassium-competitive acid blocker, after single- and multiple-oral dosing in healthy subjectsEunwoo Kim, Anhye Kim, Sojeong Yi, et al.
Pageof 30

Showing results (201-210 of 292) with videos related to

Sort By:
Pageof 30
The Pharmacogenomics Journal|May 29, 2020
Oral absorption of voriconazole is affected by SLCO2B1 c.*396T>C genetic polymorphism in CYP2C19 poor metabolizersSang Won Lee, Jaeseong Oh, Andrew HyoungJin Kim, et al.
Drug Metabolism and Pharmacokinetics|December 21, 2020
The utility of CYP3A activity endogenous markers for evaluating drug-drug interaction between sildenafil and CYP3A inhibitors in healthy subjectsSoyoung Lee, Andrew HyoungJin Kim, Sumin Yoon, et al.
British Journal of Clinical Pharmacology|May 12, 2012
Apple juice greatly reduces systemic exposure to atenololHyewon Jeon, In-Jin Jang, SeungHwan Lee, et al.
Clinical Therapeutics|January 30, 2010
The effects of ketoconazole and rifampicin on the pharmacokinetics of mirodenafil in healthy Korean male volunteers: an open-label, one-sequence, three-period, three-treatment crossover studyKwang-Hee Shin, Bo-Hyung Kim, Tae-Eun Kim, et al.
Basic & Clinical Pharmacology & Toxicology|March 21, 2013
Pharmacokinetic-pharmacodynamic modelling of biomarker response to sitagliptin in healthy volunteersBo-Hyung Kim, Sung Eun Kim, Dongwoo Kang, et al.
Clinical Drug Investigation|October 1, 2013
Relationship between absolute neutrophil count profiles and pharmacokinetics of DA-3031, a pegylated granulocyte colony-stimulating factor (pegylated-G-CSF): a dose block-randomized, double-blind, dose-escalation study in healthy subjectsLi Young Ahn, Kwang-Hee Shin, Kyoung Soo Lim, et al.
Epilepsy Research|July 30, 2015
GWAS identifies two susceptibility loci for lamotrigine-induced skin rash in patients with epilepsyHui Won Jang, So Won Kim, Yang-Je Cho, et al.
Antimicrobial Agents and Chemotherapy|May 20, 2015
Pharmacokinetics of Second-Line Antituberculosis Drugs after Multiple Administrations in Healthy VolunteersSang-In Park, Jaeseong Oh, Kyungho Jang, et al.
Scientific Reports|May 12, 2017
Pharmacometabolomics for predicting variable busulfan exposure in paediatric haematopoietic stem cell transplantation patientsBora Kim, Ji Won Lee, Kyung Taek Hong, et al.
European Journal of Clinical Pharmacology|June 17, 2018
Effect of food on the pharmacokinetics of YH4808, a potassium-competitive acid blocker, after single- and multiple-oral dosing in healthy subjectsEunwoo Kim, Anhye Kim, Sojeong Yi, et al.
Pageof 30